Able Wealth Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Able Wealth Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$5	–	612
2023 Q4	$5	Buy	+2,000	New	+$5	﹤0.01%	610

Able Wealth Management's INFI Position: Q1 2024 in Review

Able Wealth Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2024, closing a stake of 2,000 shares — an estimated $5 sold.

Able Wealth Management first reported a position in INFI in Q4 2023 and held it in 1 quarter. The position peaked at $5 in Q4 2023. 1 fund tracked by Wall St. Rank holds INFI as of Q1 2024.

Able Wealth Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
Able Wealth Management sold 2,000 Infinity Pharmaceuticals, Inc. shares in Q1 2024, an estimated $5.
Able Wealth Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2023 and held it in 1 quarter.
Able Wealth Management's Infinity Pharmaceuticals, Inc. position peaked at $5 in Q4 2023.
1 fund tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2024.

Based on Able Wealth Management's 13F filing for Q1 2024, filed 1 Nov 2024.